People. Deals. Growth.

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform

Astorg to Acquire Global Microbiology Business from Thermo Fisher Scientific

Astorg and Nordic Capital Announce Agreement to Sell Clario to Thermo Fisher Scientific

Montagu and Astorg welcome LGT Capital Partners as minority shareholder in Nemera

Astorg to Acquire Solabia, a Leading Biotech Ingredient Solutions Provider

Astorg Unveils, Nexpring Health, the New Brand Identity of its Global MedTech Company in Assisted Reproductive Technology

Astorg Continues to Bolster its Newly Combined Global Leader in Assisted Reproductive Technology by Acquiring FUJIFILM Irvine Scientific’s Medical Media Business

Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health, Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

Astorg Mid-Cap acquires a majority stake in hg medical

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

Astorg Completes Acquisition of OPEN Health From Amulet Capital Partners

Astorg Mid-Cap makes a majority investment in Avania alongside Kester Capital

Astorg to acquire global medical communications and market access platform OPEN Health from Amulet Capital Partners

Astorg to acquire leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG

Astorg and Goldman Sachs Asset Management announce they have received a binding offer and entered into exclusive negotiations with Perrigo for the sale of HRA Pharma.

Demetra to partner with Astorg

Nemera breaks ground in Brazil through Milfra acquisition

ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology

Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel

Astorg and Cinven to acquire LGC

HRA Pharma Acquires the Mederma® Brand from Merz Pharmaceuticals GmbH

Montagu and Astorg enter into an exclusive agreement to form a partnership on Nemera

Astorg to acquire Cathay Capital and OrbiMed’s stakes in Echosens

Astorg and Montagu to enter exclusive negotiations to sell their remaining majority stake in Sebia